Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) with Additional Protein Domain Synthesized in E. coli: In Vivo Osteoinductivity in Experimental Models on Small and Large Laboratory Animals


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Recombinant human bone morphogenetic protein-2 with an additional s-tag domain (s-tag-BMP-2) synthesized in E. coli is characterized by higher solubility and activity than the protein without additional s-tag domain, which increases the yield during purification and simplifies protein introduction into the osteoplastic materials. The high osteoinductivity of the demineralized bone matrix with s-tag-BMP-2 was shown on the model of regeneration of cranial defects of a critical size in mice and on the model of implantation of porous titanium matrix into defects of femoral and tibial bones in rabbits.

Об авторах

M. Bartov

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Автор, ответственный за переписку.
Email: mike.bartov@gmail.com
Россия, Moscow

A. Gromov

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

V. Manskih

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; A. N. Belozersky Research Institute of Physicochemical Biology, M. V. Lomonosov Moscow State University

Email: mike.bartov@gmail.com
Россия, Moscow; Moscow

E. Makarova

Center of Specialized Types of Medical Care, V.D. Chaklin Ural Institute of Traumatology and Orthopedics

Email: mike.bartov@gmail.com
Россия, Ekaterinburg

A. Rubshtein

M. N. Mikheev Institute of Metal Physics, Ural Division of the Russian Academy of Sciences

Email: mike.bartov@gmail.com
Россия, Ekaterinburg

M. Poponova

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

D. Savina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

K. Savin

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

K. Nikitin

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

T. Grunina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

I. Boksha

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

P. Orlova

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

M. Krivozubov

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow

M. Subbotina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; All-Russian Research Institute of Agricultural Biotechnology

Email: mike.bartov@gmail.com
Россия, Moscow; Moscow

V. Lunin

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; All-Russian Research Institute of Agricultural Biotechnology

Email: mike.bartov@gmail.com
Россия, Moscow; Moscow

A. Karyagina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; A. N. Belozersky Research Institute of Physicochemical Biology, M. V. Lomonosov Moscow State University; All-Russian Research Institute of Agricultural Biotechnology

Email: mike.bartov@gmail.com
Россия, Moscow; Moscow; Moscow

A. Gintsburg

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
Россия, Moscow


© Springer Science+Business Media, LLC, part of Springer Nature, 2017

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах